Market Place
Sourcing Support
Endo Launches Bivalirudin Injection in Ready-to-Use Vials
18 Jul 2023 //
PR NEWSWIRE
Gland Pharma launches first novel non-frozen ready-to-use bivalirudin
08 Jun 2020 //
PHARMABIZ
Hainan`s Generic Bivalirudin Receives Approval in US
25 Oct 2019 //
FDA
The Medicines Company: Innovating Innovation
11 Mar 2019 //
FORBES
Nod for Aurobindo Pharma to make, market Bivalirudin injection
30 Jul 2018 //
ECONOMIC TIMES
Aurobindo Pharma Ltd`s Generic Bivalirudin Receives Approval In US
28 Jul 2018 //
FDA
Mylan launches generic drug-delivery patch for dementia patients
09 Jul 2018 //
DRUG DEL BUSINESS
Mylan Launches Generic Angiomax® Injection
18 Jun 2018 //
PR NEWSWIRE
Mylan announces US launch of Bivalirudin for Injection
18 Jun 2018 //
BIOSPECTRUM
Mylan Institutional`s Generic Bivalirudin Receives Approval In US
05 Jun 2018 //
FDA
Apotex’s Generic Bivalirudin Receives Approval In US
07 Jul 2017 //
FDA
Mylan Institutional`s Generic Bivalirudin Receives Tentative Approval In US
10 Feb 2017 //
FDA
Mylan`s Generic Bivalirudin Receives Tentative Approval In US
02 Feb 2017 //
FDA
Appeals court hears key patent case affecting small drug makers
05 May 2016 //
STAT
Eagle Pharmaceuticals receives Response Letter from FDA on Kangio application
21 Mar 2016 //
CPHI ONLINE
U.S. FDA rejects Eagle Pharma`s blood thinner
19 Mar 2016 //
REUTERS
Federal Circuit Revokes The Medicines Co.’s Angiomax Patents
13 Jul 2015 //
FDA NEWS
The Medicines Company authorizes generic launch of Angiomax
10 Jul 2015 //
PBR
Federal Circuit Rules Against The Medicines Company in Angiomax® (bivalirudin) Patent Litigation
03 Jul 2015 //
BUSINESS WIRE
After PhIII Odyssey, The FDA Finally Gives Medicines Co. A Thumbs-Up For Cangrelor
14 Apr 2015 //
FIERCE BIOTECH
Sun Pharma settles Angiomax litigation with The Medicines Company
03 Apr 2015 //
THE ECONOMIC TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.